Stock Research for MGNX


Featured Broker: Ally Invest

Get the due diligence for another stock.


MGNX Stock Chart & Research Data

The MGNX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MGNX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MGNX Due diligence Resources & Stock Charts

The MGNX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MGNX Detailed Price Forecast - CNN Money CNN View MGNX Detailed Summary - Google Finance
Yahoo View MGNX Detailed Summary - Yahoo! Finance Zacks View MGNX Stock Research & Analysis -

Stock Analysis

TradeIdeas View MGNX Trends & Analysis - Trade-Ideas Barrons View MGNX Major Holders - Barrons
NASDAQ View MGNX Call Transcripts - NASDAQ Seeking View MGNX Breaking News & Analysis - Seeking Alpha
Spotlight View MGNX Annual Report - OTC Report View MGNX OTC Short Report -
TradeKing View MGNX Fundamentals - TradeKing Charts View MGNX SEC Filings - Bar Chart
WSJ View Historical Prices for MGNX - The WSJ Morningstar View Performance/Total Return for MGNX - Morningstar
MarketWatch View the Analyst Estimates for MGNX - MarketWatch CNBC View the Earnings History for MGNX - CNBC
StockMarketWatch View the MGNX Earnings - StockMarketWatch MacroAxis View MGNX Buy or Sell Recommendations - MacroAxis
Bullish View the MGNX Bullish Patterns - American Bulls Short Pains View MGNX Short Pain Metrics -

Social Media Mentions

StockTwits View MGNX Stock Mentions - StockTwits PennyStocks View MGNX Stock Mentions - PennyStockTweets
Twitter View MGNX Stock Mentions - Twitter Invest Hub View MGNX Investment Forum News - Investor Hub
Yahoo View MGNX Stock Mentions - Yahoo! Message Board Seeking Alpha View MGNX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MGNX - Insider Cow View Insider Transactions for MGNX - Insider Cow
CNBC View MGNX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MGNX - OTC Markets
Yahoo View Insider Transactions for MGNX - Yahoo! Finance NASDAQ View Institutional Holdings for MGNX - NASDAQ

Stock Charts

FinViz View MGNX Stock Insight & Charts - StockCharts View MGNX Investment Charts -
BarChart View MGNX Stock Overview & Charts - BarChart Trading View View MGNX User Generated Charts - Trading View

Latest Financial News for MGNX

Md. biotech to be acquired by New Jersey pharmaceutical goliath
Posted on Tuesday May 08, 2018

The final price, a bit more than a billion dollars, includes upfront cash and payments based on achieving certain milestones.

Edited Transcript of MGNX earnings conference call or presentation 7-May-18 8:30pm GMT
Posted on Monday May 07, 2018

Q1 2018 MacroGenics Inc Earnings Call

MacroGenics to Present at Deutsche Bank Health Care Conference
Posted on Monday May 07, 2018

MacroGenics, Inc. (MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will provide a corporate overview presentation at Deutsche Bank's 43rd Annual Health Care Conference in Boston on May 8, 2018 at 8:00 am (ET). A webcast of the conference presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at The Company will maintain an archived replay of this webcast on its website for 30 days after the conference.

MacroGenics: 1Q Earnings Snapshot
Posted on Monday May 07, 2018

The Rockville, Maryland-based company said it had a loss of $1.34 per share. The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was ...

Enter a stock symbol to view the stock details.